The American Academy of Pediatrics had earlier urged parents to get young children vaccinated against Covid — pushing back ...

Influenza Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical ...

With that in mind, let's consider two stocks that people in their 30s -- who are still a good distance away from retirement - ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

The American Academy of Pediatrics breaks with federal guidance, urging COVID shots for young kids as Kennedy's panel delays ...

The average short interest in the S&P 500 Health Care Index Sector (XLV) dipped slightly in July to 1.95% from 1.96% in June.

Antipathy from figures close to Trump toward mRNA technology, which underlies Moderna’s products and pipeline, has weighed on ...

Mixed options sentiment in Moderna (MRNA), with shares down 9c near $26.80. Options volume relatively light with 20k contracts traded and calls ...

The Department of Health and Human Services cut funding for messenger ribonucleic acid vaccine development earlier this month.

The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy ...

Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it ...

Despite questions coming from federal changes, Colorado’s chief medical officer says he thinks “there will be enough vaccines ...